Daré Bioscience, Inc. ( NASDAQ: DARE) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET MarDee Haring-Layton - Chief Accounting Officer Sabrina Martucci Johnson - President & Chief Executive ...
For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, ...
Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback